Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center

Diabetes Technology and Therapeutics · Published 2026-06-18 · DOI 10.1177/15209156261459274

Authors (4)

Adi Dagan, Michal Yackobovitch-Gavan, Moshe Phillip, Revital Nimri

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dagan, A., Yackobovitch-Gavan, M., Phillip, M., et al. (2026). Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center. Diabetes Technology and Therapeutics. https://doi.org/10.1177/15209156261459274

Related articles

• Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use · Diabetes Technology and Therapeutics · 2026 · Same journal
• The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events · Diabetes Technology and Therapeutics · 2026 · Same journal
• A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems · Diabetes Technology and Therapeutics · 2026 · Same journal
• Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study · Diabetes Technology and Therapeutics · 2026 · Same journal
• Primary Care and Diabetes Technologies and Treatments · Diabetes Technology and Therapeutics · 2026 · Same journal
• Glucose Predictions Improve Glycemic Control: A Digital Twin Evaluation · Diabetes Technology and Therapeutics · 2026 · Same journal
• Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes · Diabetes Technology and Therapeutics · 2026 · Same journal
• Response to: Quiros et al.: Baseline Glycemic Control and AID Efficacy in Type 1 Diabetes and Pregnancy · Diabetes Technology and Therapeutics · 2026 · Same journal
• Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial · Diabetes Technology and Therapeutics · 2026 · Same journal
• Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial · Diabetes Technology and Therapeutics · 2026 · Same journal